Cleared Traditional

K223330 - Certas Plus Programmable Valves

K223330 is an FDA 510(k) clearance for Certas Plus Programmable Valves, manufactured by Integra Lifesciences Production Corporation. The device is a Class 2 Neurology device with product code JXG cleared through the Traditional 510(k) pathway after a 93-day FDA review.

K223330 · Integra Lifesciences Production Corporation · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2023
Decision
93d
Days
Class 2
Risk

K223330 is an FDA 510(k) clearance for the Certas Plus Programmable Valves. Classified as Shunt, Central Nervous System And Components (product code JXG), Class II - Special Controls.

Submitted by Integra Lifesciences Production Corporation (Mansfield, US). The FDA issued a Cleared decision on February 1, 2023 after a review of 93 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5550 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Integra Lifesciences Production Corporation devices

FDA 510(k) Submission Details - K223330

510(k) Number K223330 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 31, 2022
Decision Date February 01, 2023
Days to Decision 93 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
55d faster than avg
Panel avg: 148d · This submission: 93d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JXG Device Classification - Class 2, Special Controls

Product Code JXG Shunt, Central Nervous System And Components
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5550
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - JXG Shunt, Central Nervous System And Components

All 177
Devices cleared under the same product code (JXG) and FDA review panel - the closest regulatory comparables to K223330.
IRRAflow Active Fluid Exchange System (AFES)
K231664 · Irras USA, Inc. · Oct 2023
External Drainage System
K221694 · Jmed(Shenzhen) Technology Limited · Feb 2023
Polaris Valve Electronic Reading Instrument
K222422 · Sophysa · Feb 2023
Reflow System Mini and ReFlow Mini Flusher
K223603 · Anuncia Medical, Inc. · Dec 2022
IRRAflow Active Fluid Exchange System (AFES)
K222471 · Irras USA · Dec 2022
Hakim Programmable Valves, Hakim Precision Fixed Pressure Valves
K221840 · Integra Lifesciences Production Corporation · Oct 2022